Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.61x
ANUHPHARMA's operating cash flow covered 61% of net income in FY 2025. Some earnings may be tied up in working capital.
Free Cash Flow
₹171.62M
ANUHPHARMA's free cash flow was ₹171.62M in FY 2025, up 104.2% from FY 2024.
Dividend Coverage
1.4x
ANUHPHARMA's free cash flow covered dividends 1.4x in FY 2025 but leaves limited surplus.
CapEx Intensity
53.8%
Capital expenditure was 53.8% of operating cash flow in FY 2025 for ANUHPHARMA, a moderate level of reinvestment.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 783.10M | 610.05M | |
| Cash flow Operating Activities | 129.25M | 371.25M | |
| Investments in PPE | -45.20M | -199.63M | |
| Cash flow Investing Activities | 9.18M | -199.09M | |
| Dividend Paid | -100.25M | -125.22M | |
| Cash flow Financing Activities | -85.68M | -48.60M | |
| Cash at beginning of period | 19.27M | 72.02M | |
| Cash at end of period | 72.02M | 195.57M | |
| Free Cash Flow | 84.05M | 171.62M |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025